1.
Preliminary observation of pemetrexed combined with cisplatin in the treatment after the treatment failure of anthracycline and taxane in advanced metastatic breast cancer
培美曲塞联合顺铂方案治疗蒽环类及紫杉类治疗失败的晚期转移性乳腺癌的初步研究
2.
A Clinical Observation of Gemcitabine and Capecitabine Combined Regimen in Advanced and Metastatic Breast Cancer Previously Treated with Anthracene Nucleus and Taxane Containing Regimens
吉西他滨联合卡培他滨治疗蒽环类和紫杉类治疗失败的晚期乳腺癌的近期疗效观察
3.
Mitomycin Combined with Cisplatin in the Treatment of 23 Cases with Anthracycline and Taxane-Resistant Advanced Breast Cancer
丝裂霉素联合顺铂治疗蒽环类及紫杉类耐药晚期乳腺癌23例
4.
Comparative Study of the Combined Chemotherapy with Paclitaxel or Antracycline for Advanced Breast Cancer
紫杉醇及蒽环类药物联合化疗治疗晚期乳腺癌的临床观察
5.
Gemcitabine Plus Cisplatin for Treatment of 34 Cases with Recurrent Breast Cancer after Anthracycines and/or Taxanes Chemotherapy
健择联合顺铂治疗蒽环类和(或)紫杉类化疗后复发性乳腺癌34例
6.
Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple negative breast cancer
紫杉类联合蒽环类的新辅助化疗方案治疗三阴乳腺癌的疗效及预后
7.
Combination of Gemcitabine and Vinorelbine in the Treatment for 24 Cases of Advanced Breast Cancer with Taxanes/Anthracyclines Resistance
吉西他滨联合长春瑞滨治疗蒽环类/紫杉类耐药晚期乳腺癌24例
8.
Clinical Comparison of Gemcitabine Combined Cisplatin Regimen Versus Vinorelbine Combined Cisplatin Regimen as Chemotherapy for Anthracycline-and Taxane-resistant Metastatic Breast Cancer
GP与NP方案治疗对蒽环类及紫杉类均耐药的转移性乳腺癌的疗效观察
9.
Gemcitabine and cisplatin combination chemotherapy as alternative agents for metastatic breast cancer patients with anthracycline and taxane resistance
吉西他滨联合顺铂治疗蒽环类及紫杉类耐药转移性乳腺癌的临床观察
10.
Paclitexal-based combination chemotherapy in the treatment of fourty-six patients with anthracycline-resistant advanced breast cancer
紫杉醇为主的联合方案治疗蒽环类耐药的晚期乳腺癌46例
11.
Efficacy and Toxicity of Gemcitabine in Combination with Vinorelbine on Metastatic Breast Cancer;
吉西他滨联合长春瑞滨治疗蒽环类和紫杉类耐药的转移性乳腺癌的疗效和安全性评价
12.
An analysis on clinical efficacy of vinorelbine combined with gemcitabine for patients with anthracycline-and taxane-refractory metastatic breast cancer
长春瑞滨联合吉西他滨治疗蒽环类和紫杉类药物耐药的转移性乳腺癌的临床疗效分析
13.
Predictive Value of FHL1 in Breast Cancer Neoadjuvant Docetaxel and Anthracycline Chemotherapy
FHL1在乳腺癌紫杉联合蒽环类药物新辅助化疗中的预测价值
14.
Effect of Neoadjuvant Chemotherapy on Expression of FHL1 in Breast Cancer
FHL1在紫杉联合蒽环类药物乳腺癌新辅助化疗中表达的变化及临床意义
15.
THE THERAPEUTIC EFFECTS OF NC THERAPY AND XD THERAPY ON BREAST CANCER AFTER THE FAILURE OF ANTHRACYCLINE THERAPY
NP方案与XD方案治疗应用蒽环类药物治疗失败的乳腺癌的疗效观察
16.
A Meta-analysis of Platinum Plus Taxanes Regimen on Treating Advanced Non-small Cell Lung Cancer
铂类联合紫杉类治疗进展期NSCLC的meta分析
17.
Treatment of anthracycline extravasation with dexrazoxane
右丙亚胺成功治疗蒽环类药物外渗的临床研究
18.
The effect of creatine phosphate on myocardial injure induced by marcellomycin
磷酸肌酸治疗蒽环类药物心肌损害的效果比较